UBS Group’s ContraFect Corporation CFRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1
| Closed | -$1 | – | 10585 |
|
|
2023
Q3 | $1 | Sell |
1
-2,520
| -100% | -$2.39K | ﹤0.01% | 9398 |
|
|
2023
Q2 | $3.78K | Buy |
2,521
+2,520
| +252,000% | +$3.98K | ﹤0.01% | 7600 |
|
|
2023
Q1 | $2 | Sell |
1
-146
| -99% | -$686 | ﹤0.01% | 9512 |
|
|
2022
Q4 | $1.18K | Sell |
147
-222
| -60% | -$2.57K | ﹤0.01% | 9932 |
|
|
2022
Q3 | $5K | Buy |
369
+367
| +18,350% | +$18.5K | ﹤0.01% | 9303 |
|
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 11767 |
|
|
2022
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 10143 |
|
|
2021
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 11433 |
|
|
2021
Q3 | $1K | Sell |
2
-4
| -67% | -$1.25K | ﹤0.01% | 9447 |
|
|
2021
Q2 | $2K | Sell |
6
-58
| -91% | -$19K | ﹤0.01% | 9108 |
|
|
2021
Q1 | $25K | Sell |
64
-23
| -26% | -$9.92K | ﹤0.01% | 7199 |
|
|
2020
Q4 | $35K | Buy |
87
+79
| +988% | +$34.2K | ﹤0.01% | 6522 |
|
|
2020
Q3 | $4K | Sell |
8
-46
| -85% | -$20.9K | ﹤0.01% | 7494 |
|
|
2020
Q2 | $28K | Buy |
54
+48
| +800% | +$23.6K | ﹤0.01% | 6335 |
|
|
2020
Q1 | $3K | Hold |
6
| – | – | ﹤0.01% | 7579 |
|
|
2019
Q4 | $3K | Hold |
6
| – | – | ﹤0.01% | 7806 |
|
|
2019
Q3 | $2K | Sell |
6
-35
| -85% | -$11.8K | ﹤0.01% | 7795 |
|
|
2019
Q2 | $16K | Buy |
41
+13
| +46% | +$5.09K | ﹤0.01% | 6792 |
|
|
2019
Q1 | $9K | Buy |
28
+13
| +87% | +$5.63K | ﹤0.01% | 6912 |
|
|
2018
Q4 | $18K | Buy |
15
+9
| +150% | +$14.3K | ﹤0.01% | 6892 |
|
|
2018
Q3 | $10K | Hold |
6
| – | – | ﹤0.01% | 7189 |
|
|
2018
Q2 | $11K | Sell |
6
-7
| -54% | -$10.3K | ﹤0.01% | 7100 |
|
|
2018
Q1 | $17K | Buy |
13
+6
| +86% | +$7.4K | ﹤0.01% | 6534 |
|
|
2017
Q4 | $6K | Buy |
7
+1
| +17% | +$827 | ﹤0.01% | 7337 |
|
|
2017
Q3 | $5K | Sell |
6
-6
| -50% | -$5.67K | ﹤0.01% | 7262 |
|
|
2017
Q2 | $14K | Buy |
12
+6
| +100% | +$7.03K | ﹤0.01% | 6566 |
|
|
2017
Q1 | $9K | Hold |
6
| – | – | ﹤0.01% | 6709 |
|
|
2016
Q4 | $8K | Sell |
6
-4
| -40% | -$7.06K | ﹤0.01% | 7056 |
|
|
2016
Q3 | $19K | Buy |
10
+5
| +100% | +$9.82K | ﹤0.01% | 6352 |
|
|
2016
Q2 | $11K | Buy |
5
+3
| +150% | +$7.62K | ﹤0.01% | 6746 |
|
|
2016
Q1 | $4K | Buy |
+2
| New | +$5.67K | ﹤0.01% | 7129 |
|
|
2015
Q4 | – | Sell |
-1
| Closed | -$4K | – | 8694 |
|
|
2015
Q3 | $4K | Sell |
1
-2
| -67% | -$7.89K | ﹤0.01% | 7868 |
|
|
2015
Q2 | $12K | Buy |
+3
| New | +$12.2K | ﹤0.01% | 7348 |
|
|
2015
Q1 | – | Sell |
-2
| Closed | -$7.27K | – | 8617 |
|
|
2014
Q4 | $7K | Buy |
+2
| New | +$5.01K | ﹤0.01% | 8745 |
|
Other funds holding CFRX
UBS Group's CFRX Position: Q4 2023 in Review
UBS Group sold out of ContraFect Corporation (CFRX) in Q4 2023, closing a stake of 1 share — an estimated $1 sold.
UBS Group first reported a position in CFRX in Q4 2014 and held it in 34 quarters. The position peaked at $35K in Q4 2020. 2 funds tracked by Wall St. Rank hold CFRX as of Q4 2023.
- UBS Group reported no remaining ContraFect Corporation position as of Q4 2023 after selling out during the quarter.
- UBS Group sold 1 ContraFect Corporation share in Q4 2023, an estimated $1.
- UBS Group first reported a position in ContraFect Corporation in Q4 2014 and held it in 34 quarters.
- UBS Group's ContraFect Corporation position peaked at $35K in Q4 2020.
- 2 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2023.
Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.